강은주 프로필 사진

강은주

Kang, Eun Joo
Scopus ORCID

자료 필터

자료유형

발행연도

2010 ~ 2030
2010 2030

키워드

언어

전체 172건 중 51번부터 60번까지의 결과를 표시합니다.

2024
Article

Impact of PIK3CA and cell cycle pathway genetic alterations on durvalumab efficacy in patients with head and neck squamous cell carcinoma: Post hoc analysis of TRIUMPH study

  • Kim, Dong Hyun ; 
  • Lim, Seung Taek ; 
  • Kim, Hye Ryun ; 
  • Kang, Eun Joo ; 
  • Ahn, Hee Kyung ; 
  • 외 10명
  • 2024-04
  • Oral Oncology
  • Pergamon Press Ltd.
Article

Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With EGFR- or ALK-Rearranged or Translocated Non–Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04)

  • Park, Sehhoon ; 
  • Kim, Tae Min ; 
  • Han, Ji-Youn ; 
  • Lee, Gyeong-Won ; 
  • Shim, Byoung Yong ; 
  • ... Kang, Eun Joo ; 
  • ... Kim, Ju Won ; 
  • 외 17명
  • 2024-04
  • Journal of Clinical Oncology
  • American Society of Clinical Oncology
Article

Phase II study of nivolumab in patients with genetic alterations in DNA damage repair and response who progressed after standard treatment for metastatic solid cancers (KM-06)

  • 2024-03
  • Journal for ImmunoTherapy of Cancer
  • BioMed Central
2023
Article

Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes as a predictive biomarker for axitinib in adenoid cystic carcinoma

  • Kim, Dong Hyun ; 
  • Lim, Yoojoo ; 
  • Ock, Chan-Young ; 
  • Park, Gahee ; 
  • Park, Seonwook ; 
  • ... Kang, Eun Joo ; 
  • 외 13명
  • 2023-12
  • Head and Neck
  • John Wiley & Sons Inc.
Conference

Final Overall Survival Analysis of Osimertinib for Patients with NSCLC Harboring Uncommon EGFR Mutations (KCSG-LU15-09)

  • Cho, J. H. ; 
  • Lim, S. H. ; 
  • An, H. J. ; 
  • Kim, K. H. ; 
  • Park, K. U. ; 
  • ... Kang, E. J. ; 
  • 외 7명
  • 2023-11
  • 싱가포르
Article

A phase 2 multicenter study of docetaxel-PM and trastuzumab-pkrb combination therapy in recurrent or metastatic salivary gland carcinomas

  • 2023-10
  • Cancer
  • John Wiley & Sons Inc.